Related Experiment Videos
Clinical trials referral resource. Colon cancer
Oncology (Williston Park, N.Y.)
|August 1, 1994
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A phase II trial of lenalidomide plus rituximab in previously untreated follicular non-Hodgkin's lymphoma (NHL): CALGB 50803 (Alliance).
Annals of oncology : official journal of the European Society for Medical Oncology·2017
Optimal sequencing of ibrutinib, idelalisib, and venetoclax in chronic lymphocytic leukemia: results from a multicenter study of 683 patients.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
Current Status of U.S. Clinical Trials in Chronic Lymphocytic Leukemia.
Leukemia & lymphoma·2016
Chronic phalaris toxicity in eastern grey kangaroos (Macropus giganteus).
Australian veterinary journal·2014
Advancing Multidisciplinary Care and Health Equity in Metastatic Breast Cancer.
Oncology (Williston Park, N.Y.)·2026
Access to Care and Drug Prices: Recent Department of Health and Human Services Guidance.
Oncology (Williston Park, N.Y.)·2026
Clinical Outcomes of Acute Pancreatitis in Patients With Multiple Myeloma.
Oncology (Williston Park, N.Y.)·2026
Primary Malignant Melanoma of the Colon: A Rare and Challenging Diagnosis.
Oncology (Williston Park, N.Y.)·2026
Emerging T-Cell Engagers and Novel Immunotargets in Multiple Myeloma.
Oncology (Williston Park, N.Y.)·2026
Use of glucagon-like peptide-1 receptor agonists is associated with inadequate bowel preparation for colonoscopy in patients with diabetes.
Journal of diabetes investigation·2026
Large-scale simulation of coverage and error rate tradeoffs for cancer detection in cell-free DNA whole-genome sequencing.
Bioinformatics (Oxford, England)·2026
Deciphering HPV-Associated Immune Evasion in Cervical Cancer Through Multi-Omics Profiling and Computational Screening.
Analytical cellular pathology (Amsterdam)·2026
From fragmentation to focus: building collaborative networks for rare cancer research - the Italian TYME network as a model for care and innovation?
Expert review of anticancer therapy·2026